ISRCTN07197979已完成不适用
Testosterone Replacement in Diabetes Mellitus with Vascular Disease
Record Provided by the NHSTCT Register - 2007 Update - Department of Health0 个研究点目标入组 30 人开始时间: 2007年9月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •1. Men with Diabetes M, hypogonadism and PVD
- •2. Older than 40 years old
- •3.Type 2 Diabetes Mellitus treated with insulin with or without oral hypoglycaemics
- •4. Serum testosterone less than 12mmol/L on two consecutive morning samples taken on different days
- •5. Symptoms attributable to hypogonadism in the opinion of the investigator
- •6. Agreement to maintain, diabetic antihypertensive and antilipid treatments at prior doses for the duration of the study
- •7. Ability to give written informed consent and verbal and written explanation in the English language
- •8. Ability to comply with all study requirements
排除标准
- •1. Current or previous breast cancer
- •2. Current or previous prostate cancer
- •3. Raised prostate specific antigen (PSA) or abnormal digital rectal examination suspicious of prostate cancer unless diagnosis excluded after specialist urology opinion and/or prostate biopsy
- •4. Severe symptoms of benign prostatic hypertrophy (prostatism)
- •5. Treatment with testosterone in the 3 months prior to the trial.
- •6. Investigational drug treatment in the 3 months prior to the trial
- •7. Any other reason considered significant by the investigators at the time of assessment
研究者
相似试验
进行中（未招募）
不适用
Testosterone therapy of patients with type 2 diabetes mellitusType 2 diabetes mellitus (T2DM) is a common endocrine disorder caracterized by hyperinsulinaemia and insulin resistance. We aim to investigate if testosterone therapy can improve body composition, insulin sensitivity, lipid metabolism and quality of life in men with low to normal bioavailable testosterone levels (<7.3 nmol/l) and T2DM.MedDRA version: 14.1Level: LLTClassification code 10043368Term: Testosterone decreasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 14.1Level: LLTClassification code 10012613Term: Diabetes mellitus non-insulin-dependentSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-002102-73-DKEndokrinologisk afd. M
已完成
2 期
Reandron in Diabetic Men Witn Low Testosterone LevelHypogonadismType 2 DiabetesNCT00613782Austin Health88
已完成
不适用
Effect of Testosterone replacement on glycaemic control and insulin sensitivity in hypogonadal men with type 2 diabetesutritional, Metabolic, Endocrine: HypogonadismNutritional, Metabolic, EndocrineHypogonadismISRCTN57267165Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)20
进行中（未招募）
1 期
Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic riskTesticular cancerEUCTR2015-004430-96-NLniversity Medical Center Groningen50
招募中
不适用
Short-term Testosterone replacement in testicular cancer survivors to treat overweight and improve cardiometabolic risk: a pilot studytesticular cancerNL-OMON50478niversitair Medisch Centrum Groningen50